Propanc Biopharma
PPCB----
Propanc Biopharma (PPCB)
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic,...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- Unusual Whales · Jul 21 at 07:32 AM
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
- PUBT · Jul 14 at 03:02 PM
Propanc Biopharma names Carlo Campiciano to board after Van Broekhoven retirement
- benzinga_article · Jul 7 at 04:05 PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
- PUBT · Jul 7 at 07:33 AM
Propanc Biopharma signs MOU with Avance Clinical for PRP Phase 1b trial delivery
- Price Alert · Jul 6 at 04:37 AM
Pre-market hot trades in US stocks: Propanc Biopharma pre-market down 7.19%; Western Digital pre-market up 4.73%
- rttnews · Jul 3 at 12:19 AM
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
